One River Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-298
Closed -$108K – 197
2026
Q2
$108K Buy
298
+85
+40% +$29.1K 0.03% 210
2026
Q1
$74.9K Buy
213
+186
+689% +$66.3K 0.03% 232
2025
Q4
$8.84K Buy
+27
New +$8.56K ﹤0.01% 226
2025
Q3
– Sell
-10,045
Closed -$2.81M – 169
2025
Q2
$2.81M Buy
10,045
+5,835
+139% +$1.65M 6.18% 4
2025
Q1
$1.31M Buy
4,210
+3,658
+663% +$1.08M 0.2% 60
2024
Q4
$143K Buy
552
+161
+41% +$47.8K 0.01% 188
2024
Q3
$126K Sell
391
-30
-7% -$9.8K 0.02% 249
2024
Q2
$132K Buy
+421
New +$124K 0.01% 211

Other funds holding AMGN

One River Asset Management's AMGN Position: Q3 2026 in Review

One River Asset Management sold out of Amgen (AMGN) in Q3 2026, closing a stake of 298 shares — an estimated $108K sold.

One River Asset Management first reported a position in AMGN in Q2 2024 and held it in 8 quarters. The position peaked at $2.81M in Q2 2025. 3,272 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • One River Asset Management reported no remaining Amgen position as of Q3 2026 after selling out during the quarter.
  • One River Asset Management sold 298 Amgen shares in Q3 2026, an estimated $108K.
  • One River Asset Management first reported a position in Amgen in Q2 2024 and held it in 8 quarters.
  • One River Asset Management's Amgen position peaked at $2.81M in Q2 2025.
  • 3,272 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on One River Asset Management's 13F filing for Q3 2026, filed 21 Oct 2026.